Answers to our most frequently asked questions about the registry

Everyone can play a role in preeclampsia research. Enroll Today login

The Preeclampsia Registry is a valuable resource that you can turn to when posing new questions, testing new hypotheses, and building study cohorts. As a “living database” that i...

According to the World Health Organization, preeclampsia is one of the least funded areas of research, especially when considered against Disability Adjusted Life Years (DALYs). The Preeclampsia Found...

The Letter of Intent period is CLOSED for the 2020 Peter Joseph Pappas Research Grants funding program. Decisions will be rendered in December 2020 and the next funding round will be announced next ye...

TREATMENT Results of a trial to test a new medication for preterm preeclampsia: the PRESERVE-1 Trial AJOG Preterm preeclampsia is a rare form of preeclampsia that occurs at 23-30 weeks of...

LONG-TERM EFFECTS Adverse Pregnancy Outcomes and Long-term Maternal Kidney Disease: A Systematic Review and Meta-analysis JAMA Network Open Researchers sought to combine the available data to s...

RISK Early and late onset preeclampsia and small for gestational age risk in subsequent pregnancies PLOS One Having had preeclampsia before is a risk factor for having preeclampsia in future pr...

Melbourne, FL – January 30, 2020 – The Preeclampsia Foundation announced the recipients of its 2020 Peter Joseph Pappas Research Grants, a funding program designed to accelerate preec...

Question:  I would like to know the correlation and prevalence of HELLP / Preeclampsia and Polycystic Kidney Disease. Answer: Women with polycystic kidney disease (PKD) are at higher risk of a...